News

Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how ...
Dr. Omar H. Llaguna, specialist in surgical oncology, programs a HistoSonics medical device for targeting a medium that ...
At Miami-Dade’s public hospital system Jackson Health, new advancements in genetic research recently helped doctors modify a ...
Families with a history of breast or ovarian cancer may soon have access to a powerful new tool that can help identify cancer ...
Shanghai Yao Yuan Biotechnology Ltd., also known as Drug Farm, is advancing a portfolio of immune-modulating therapies for various indications including hepatitis B virus, hepatocellular cancer and a ...
Researchers mapped Y chromosome loss across thousands of individual cells from human cancers, with disturbing results.
Justin Taylor, M.D., a physician-scientist at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller ...
A gene-editing delivery system developed by UT Southwestern Medical Center researchers simultaneously targeted the liver and ...
The ROBO Global Healthcare Technology & Innovation Index offers unique, targeted exposure to innovators. Click to read.
Eli Lilly’s LLY recent announcement to acquire Verve Therapeutics, Inc VERV, a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease, has put the spotlight on ...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...